Publications by authors named "Kenichi Hiramoto"

Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular concentrations and effects of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP). The role of PDEs in malignant tumor cells is still uncertain. The role of PDEs, especially PDE2, in human malignant melanoma PMP cell line was examined in this study.

View Article and Find Full Text PDF

Cyclic adenosine 3'5'-monophosphate (cAMP) and cyclic guanosine 3'5'-monophosphate (cGMP) are critical intracellular messengers involved in transduction of signals generated by a wide variety of extracellular stimuli, including growth factors, cytokines, peptide hormones, light and neurotransmitters. These messengers modulate many fundamental biological processes, including myocardial contractility, platelet aggregation, vascular smooth muscle relaxation, proliferation and apoptosis, etc. Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP, and are important in regulating intracellular concentrations and biological actions of these signal-transducing molecules.

View Article and Find Full Text PDF

Submandibular Gland Mucocele:The mucocele occuring in the submandibular region is rare, most cases originate in the sublingual gland. Here, we report a rare case of mucocele originating in the submandibular gland. In this report, we present such a case in a 7-year-old boy, who was treated by an extirpation of cyst with submandibular and sublingual gland

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the role of phosphodiesterase 4 (PDE4) in HMG human malignant melanoma cells, finding that PDE4 activity is present and can be inhibited by rolipram.
  • Specific PDE4 inhibitors and forskolin were shown to increase intracellular cAMP levels, which then influenced cell growth.
  • The research indicates that targeting PDE4 could potentially be a new therapeutic strategy for treating human malignant melanoma, as previous studies have not explored this positive regulation of cell growth through PDE4 inhibition.
View Article and Find Full Text PDF

The Fas receptor is a potentially valuable therapeutic target in cancer treatment. However, the clinical application of antibodies directed to this target is hindered by their serious side effects in vivo, including liver toxicity. One murine monoclonal antibody, mHFE7A, binds both to human Fas and murine Fas, without inducing any obvious side effects.

View Article and Find Full Text PDF

The Fas/FasL signalling system plays an important role in chemotherapy-induced apoptosis in several different cell types. After interferon-gamma (IFN-gamma) treatment, we have previously reported a significant increase in Fas expression in oral malignant melanoma cell lines (MMN9, PMP, MAA, HMG) in vitro, and combination therapy using IFN-gamma and anti-Fas antibody (CH-11) has shown a synergistic anti-proliferative effect in MMN9 cells. There have been several in-vitro studies using CH-11, but there are few reports of its anti-tumour effect in vivo.

View Article and Find Full Text PDF

Phosphodiesterase (PDE) 3 has been characterized in isolated rat submandibular acini. PDE3 activity was detected in homogenates of isolated rat submandibular acini; little or no PDE3 activity was found in ducts. About 62% of PDE3 activity in the acini was recovered in the supernatant fractions; 38% in particulate fractions.

View Article and Find Full Text PDF

The purpose of this study was to evaluate the anti-tumor effects of osteosarcoma (HOSM-1) cells via transfer of the Bax gene using a cationic liposome. We evaluated the levels of Bax, Bcl-xL, Bcl-2 and cytochrome c expression by Western blot analysis, and caspase-9 and -3 activities were determined in a colorimetric assay. Apoptosis was detected using a TUNEL assay, and cell growth inhibition was determined in an MTT assay.

View Article and Find Full Text PDF